ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "sex bias"

  • Abstract Number: 812 • 2019 ACR/ARP Annual Meeting

    Sex Differences in Autoimmunity and Cardiovascular Risk Could Be Associated with Altered Treg Phenotype and Lipoprotein Metabolism

    George Robinson1, Kirsty Waddington 1, Anna Radziszewska 1, Hannah Peckham 1, David A Isenberg 2, Yiannis Ioannou 1, Coziana Ciurtin 3, Ines Pineda-Torra 1 and Elizabeth Jury 1, 1University College London, London, United Kingdom, 2Centre for Rheumatology, London, United Kingdom, 3Centre for Adolescent Rheumatology, University College London London, UK, Londond, United Kingdom

    Background/Purpose: Males and females have altered immune responses resulting in variation in autoimmune risk. Sex differences exist in the frequency and activity of immune-cell subsets…
  • Abstract Number: 2023 • 2019 ACR/ARP Annual Meeting

    Gene-Expression Analysis of Male and Female SLE Patients Reveals Candidate Pathogenic Pathways

    MIKHAIL OLFERIEV1, David Fernandez 2, Dina Greenman 1, Mary Peng 1, Kyriakos Kirou 1 and Mary Crow 1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Mary Kirkland Center for Lupus Research, New York, NY

    Background/Purpose: The female predisposition for development of multiple autoimmune diseases is well recognized. The female to male ratio reaches a maximum during the reproductive years…
  • Abstract Number: 2687 • 2014 ACR/ARHP Annual Meeting

    Estrogen-Mediated STAT1 Activation By Estrogen Receptor a Induces TLR8 Expression: A Novel Pathogenic Mechanism in Systemic Lupus Erythematosus

    Nicholas Young1, Giancarlo Valiente2, Lai-Chu Wu3, Michael Bruss4, Stacy Ardoin2, Craig Burd5 and Wael N. Jarjour6, 1Ohio State University, Columbus, OH, 2Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 5Molecular & Cellular Biochemistry, The Ohio State University, Columbus, OH, 6Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Many autoimmune disorders, including Systemic Lupus Erythematosus (SLE) display female gender predominance.  Previous studies have demonstrated significant hormonal contributions to SLE pathogenesis, including estrogen,…
  • Abstract Number: 2686 • 2014 ACR/ARHP Annual Meeting

    Gene Array Analysis Reveals Unique Estrogen Signature in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus

    Stephanie Amici1, Nicholas A. Young2, Lai-Chu Wu2, Mireia Guerau1 and Wael N. Jarjour3, 1Health and Rehab Sciences, The Ohio State University, Columbus, OH, 2Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disorder predominately affecting females in the reproductive age range.  Estrogen is present at higher levels in this…
  • Abstract Number: 2014 • 2013 ACR/ARHP Annual Meeting

    Cigarette Smoking and Male Sex Are Independent Risk Factors For Ocular Sarcoidosis

    Adam Janot1, Dörte Huscher2, McCall Walker3, Harmanjot K. Grewal4, Mary Yu1, Matthew R. Lammi5,6 and Lesley Ann Saketkoo7,8, 1Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, 2German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany, 3LSUHSC School of Medicine, New Orleans, LA, 4Rheumatology, Lousiana State University Health Sciences Center, New Orleans, LA, 5Section of Pulmonary and Critical Care Medicine, LSU Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, 6Louisiana State University Health Sciences Center, Pulmonary and Critical Medicine, New Orleans, LA, 7LSU Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, 8Scleroderma and Sarcoidosis Patient Care and Research Center, Rheumatology and Pulmonary Medicine, Louisiana State University Health Sciences Center, New Orleans, LA

    Background/Purpose: Sarcoidosis is a multi-organ system granulomatous disease of unknown origin with an incidence of 1-40/100,000.  Though pulmonary manifestations are predominant, ocular morbidity is characteristic. …
  • Abstract Number: 628 • 2013 ACR/ARHP Annual Meeting

    Estrogen Modulates The Expression Of Endosome-Associated Toll-Like Receptor 8 Through Estrogen Receptor-α Which May Contribute To Sex-Bias In Systemic Lupus Erythematosus

    Nicholas A. Young1, Lai-Chu Wu1, Craig Burd2, Alexandra Friedman1, Benjamin Kaffenberger1, Murugesan Rajaram3, Larry S. Schlesinger4, Hayley James5, Margaret Shupnik6 and Wael N. Jarjour7, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Molecular Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, 3Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH, 4Center for Microbial Interface Biology, The Ohio State University Wexner Medical Center, Columbus, OH, 5Asthma, Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, VA, 6Endocrinology; Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, 7Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Epidemiological data suggests that females of child-bearing age are more resistant to infectious disease.  The sex hormone estrogen (E2) is present at elevated levels…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology